Immunohistochemical profile of vegf, tgf-ß and pge2in human pterygium and normal conjunctiva: Experimental studyand review of the literature

E. Bianchi, F. Scarinci, C. Grande, R. Plateroti, R. Plateroti, A. M. Plateroti, L. Fumagalli, P. Capozzi, J. Feher, M. Artico

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Human pterygium is made up of chronic proliferative fibro-vascular tissue growing on the ocular surface. This disease exhibits both degenerative and hyperplastic properties. Some fibroangiogenic factors have recently been shown to play a potential role in fibrovascular diseases via the angiogenesis process. The aim of this study is to evaluate VEGF, TGF-β; and PGE2 expression in the epithelial, endothelial and stromal cells of human pterygium and normal conjunctiva in order to determine whether these factors participate in the development of pterygium. Ten specimens from patients with pterygium and two normal conjunctivas (cadavers) were analyzed by immunohistochemistry using specific antibodies against these growth factors. The technique used was ABC/HRP (Avidin complexed with biotinylated peroxidase). Immunoreactivity of VEGF was significantly increased in the epithelium, vascular endothelium and stromal cells in primary pterygium as compared with normal conjunctiva. A moderate expression of TGF-β; in the pterygium was observed in the epithelial and stromal layers. On the contrary, immunolabeling of this growth factor in the human normal conjunctiva was weak. PGE2 was strongly expressed in the epithelium of patients with pterygium, as in control conjunctival tissues, and the immunolabeling was moderate in the stroma from the same patients. Our results suggest that these growth factors may contribute to the progression of primary pterygium by increasing angiogenesis, thus leading to the formation of new blood vessels from the pre-existing vasculature. We conclude that VEGF, TGF-β; and PGE2 may be potential therapeutic targets in the treatment of this disease although proof of this evidence requires further studies.

Original languageEnglish
Pages (from-to)607-615
Number of pages9
JournalInternational Journal of Immunopathology and Pharmacology
Volume25
Issue number3
Publication statusPublished - Jul 2012

Fingerprint

Pterygium
Conjunctiva
Vascular Endothelial Growth Factor A
Dinoprostone
Intercellular Signaling Peptides and Proteins
Stromal Cells
Blood Vessels
Epithelium
Vascular Endothelium
Cadaver
Peroxidase
Endothelial Cells
Epithelial Cells
Immunohistochemistry
Antibodies

Keywords

  • Conjunctiva
  • Immunohistochemistry
  • Pge
  • Pterygium
  • TGF-beta
  • VEGF

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Cite this

Immunohistochemical profile of vegf, tgf-ß and pge2in human pterygium and normal conjunctiva : Experimental studyand review of the literature. / Bianchi, E.; Scarinci, F.; Grande, C.; Plateroti, R.; Plateroti, R.; Plateroti, A. M.; Fumagalli, L.; Capozzi, P.; Feher, J.; Artico, M.

In: International Journal of Immunopathology and Pharmacology, Vol. 25, No. 3, 07.2012, p. 607-615.

Research output: Contribution to journalArticle

Bianchi, E, Scarinci, F, Grande, C, Plateroti, R, Plateroti, R, Plateroti, AM, Fumagalli, L, Capozzi, P, Feher, J & Artico, M 2012, 'Immunohistochemical profile of vegf, tgf-ß and pge2in human pterygium and normal conjunctiva: Experimental studyand review of the literature', International Journal of Immunopathology and Pharmacology, vol. 25, no. 3, pp. 607-615.
Bianchi, E. ; Scarinci, F. ; Grande, C. ; Plateroti, R. ; Plateroti, R. ; Plateroti, A. M. ; Fumagalli, L. ; Capozzi, P. ; Feher, J. ; Artico, M. / Immunohistochemical profile of vegf, tgf-ß and pge2in human pterygium and normal conjunctiva : Experimental studyand review of the literature. In: International Journal of Immunopathology and Pharmacology. 2012 ; Vol. 25, No. 3. pp. 607-615.
@article{25198e37891b4cb890fab16ee9917f32,
title = "Immunohistochemical profile of vegf, tgf-{\ss} and pge2in human pterygium and normal conjunctiva: Experimental studyand review of the literature",
abstract = "Human pterygium is made up of chronic proliferative fibro-vascular tissue growing on the ocular surface. This disease exhibits both degenerative and hyperplastic properties. Some fibroangiogenic factors have recently been shown to play a potential role in fibrovascular diseases via the angiogenesis process. The aim of this study is to evaluate VEGF, TGF-β; and PGE2 expression in the epithelial, endothelial and stromal cells of human pterygium and normal conjunctiva in order to determine whether these factors participate in the development of pterygium. Ten specimens from patients with pterygium and two normal conjunctivas (cadavers) were analyzed by immunohistochemistry using specific antibodies against these growth factors. The technique used was ABC/HRP (Avidin complexed with biotinylated peroxidase). Immunoreactivity of VEGF was significantly increased in the epithelium, vascular endothelium and stromal cells in primary pterygium as compared with normal conjunctiva. A moderate expression of TGF-β; in the pterygium was observed in the epithelial and stromal layers. On the contrary, immunolabeling of this growth factor in the human normal conjunctiva was weak. PGE2 was strongly expressed in the epithelium of patients with pterygium, as in control conjunctival tissues, and the immunolabeling was moderate in the stroma from the same patients. Our results suggest that these growth factors may contribute to the progression of primary pterygium by increasing angiogenesis, thus leading to the formation of new blood vessels from the pre-existing vasculature. We conclude that VEGF, TGF-β; and PGE2 may be potential therapeutic targets in the treatment of this disease although proof of this evidence requires further studies.",
keywords = "Conjunctiva, Immunohistochemistry, Pge, Pterygium, TGF-beta, VEGF",
author = "E. Bianchi and F. Scarinci and C. Grande and R. Plateroti and R. Plateroti and Plateroti, {A. M.} and L. Fumagalli and P. Capozzi and J. Feher and M. Artico",
year = "2012",
month = "7",
language = "English",
volume = "25",
pages = "607--615",
journal = "International Journal of Immunopathology and Pharmacology",
issn = "0394-6320",
publisher = "Biomedical Research Press s.a.s.",
number = "3",

}

TY - JOUR

T1 - Immunohistochemical profile of vegf, tgf-ß and pge2in human pterygium and normal conjunctiva

T2 - Experimental studyand review of the literature

AU - Bianchi, E.

AU - Scarinci, F.

AU - Grande, C.

AU - Plateroti, R.

AU - Plateroti, R.

AU - Plateroti, A. M.

AU - Fumagalli, L.

AU - Capozzi, P.

AU - Feher, J.

AU - Artico, M.

PY - 2012/7

Y1 - 2012/7

N2 - Human pterygium is made up of chronic proliferative fibro-vascular tissue growing on the ocular surface. This disease exhibits both degenerative and hyperplastic properties. Some fibroangiogenic factors have recently been shown to play a potential role in fibrovascular diseases via the angiogenesis process. The aim of this study is to evaluate VEGF, TGF-β; and PGE2 expression in the epithelial, endothelial and stromal cells of human pterygium and normal conjunctiva in order to determine whether these factors participate in the development of pterygium. Ten specimens from patients with pterygium and two normal conjunctivas (cadavers) were analyzed by immunohistochemistry using specific antibodies against these growth factors. The technique used was ABC/HRP (Avidin complexed with biotinylated peroxidase). Immunoreactivity of VEGF was significantly increased in the epithelium, vascular endothelium and stromal cells in primary pterygium as compared with normal conjunctiva. A moderate expression of TGF-β; in the pterygium was observed in the epithelial and stromal layers. On the contrary, immunolabeling of this growth factor in the human normal conjunctiva was weak. PGE2 was strongly expressed in the epithelium of patients with pterygium, as in control conjunctival tissues, and the immunolabeling was moderate in the stroma from the same patients. Our results suggest that these growth factors may contribute to the progression of primary pterygium by increasing angiogenesis, thus leading to the formation of new blood vessels from the pre-existing vasculature. We conclude that VEGF, TGF-β; and PGE2 may be potential therapeutic targets in the treatment of this disease although proof of this evidence requires further studies.

AB - Human pterygium is made up of chronic proliferative fibro-vascular tissue growing on the ocular surface. This disease exhibits both degenerative and hyperplastic properties. Some fibroangiogenic factors have recently been shown to play a potential role in fibrovascular diseases via the angiogenesis process. The aim of this study is to evaluate VEGF, TGF-β; and PGE2 expression in the epithelial, endothelial and stromal cells of human pterygium and normal conjunctiva in order to determine whether these factors participate in the development of pterygium. Ten specimens from patients with pterygium and two normal conjunctivas (cadavers) were analyzed by immunohistochemistry using specific antibodies against these growth factors. The technique used was ABC/HRP (Avidin complexed with biotinylated peroxidase). Immunoreactivity of VEGF was significantly increased in the epithelium, vascular endothelium and stromal cells in primary pterygium as compared with normal conjunctiva. A moderate expression of TGF-β; in the pterygium was observed in the epithelial and stromal layers. On the contrary, immunolabeling of this growth factor in the human normal conjunctiva was weak. PGE2 was strongly expressed in the epithelium of patients with pterygium, as in control conjunctival tissues, and the immunolabeling was moderate in the stroma from the same patients. Our results suggest that these growth factors may contribute to the progression of primary pterygium by increasing angiogenesis, thus leading to the formation of new blood vessels from the pre-existing vasculature. We conclude that VEGF, TGF-β; and PGE2 may be potential therapeutic targets in the treatment of this disease although proof of this evidence requires further studies.

KW - Conjunctiva

KW - Immunohistochemistry

KW - Pge

KW - Pterygium

KW - TGF-beta

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=84868015527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868015527&partnerID=8YFLogxK

M3 - Article

C2 - 23058011

AN - SCOPUS:84868015527

VL - 25

SP - 607

EP - 615

JO - International Journal of Immunopathology and Pharmacology

JF - International Journal of Immunopathology and Pharmacology

SN - 0394-6320

IS - 3

ER -